CLINICAL EVALUATION OF ELADI CHURNA AND DRAKSHARISHTA IN THE MANAGEMENT OF KASA (STABLE CHRONIC BRONCHITIS)

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 105 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Age of the patient is between 18 to 65 years.
•2.Patients of chronic stable bronchitis suffering from minimum of two years.(Chronic bronchitis is defined clinically as chronic Productive cough for 3 months in each of 2 successive years in that patient in whom other causes of productive cough have been excluded.)
•3.Stable symptoms for the past 2 weeks i.e. unchanged amount & color of daily sputum
•4. FEV1 of > 80%
•5.Patient willing and able to participate in the study for 16 weeks.

•1.Patient is having another diagnosed pulmonary disorder (E.g. Emphysema, cor pulmonale, cyanosis, pneumonia, asthma, cystic fibrosis, tuberculosis, lung cancer etc.)
•2.Patient of Diabetes Mellitus
•3.Patient is having poorly controlled HTN (BP >= 160/100 mmHg).
•4.Patient is on prolonged ( > 6 Weeks) medication with corticosteroids, bronchodilators, mast-cell stabilizers, antidepressants, anticholinergics etc. or any other drugs that may have an influence on the outcome of the study
•5.Patient is suffering from major systemic illness necessitating long term drug treatment (e.g. Rheumatoid arthritis, Tuberculosis & psycho-neuro-endocrinal disorders etc.)
•6.Patient is having the past history of atrial fibrillation, acute coronary syndrome, MI, stroke or severe arrhythmia in the last 6 months.
•7.Patient is having symptoms of heart failure along with clinical evidences.
•8.Patients is suffering from concurrent serious hepatic disorder (AST &/or ALT, Total Bilirubin & ALP > 2 times upper normal limit) or renal disorder (S. creatinine > 1.2 mg/dl).
•9.Patient is a smoker/alcoholic &/or drug abuser.
•10.Patient has completed participation in another clinical trial during the past six months.
•11.Patientâ??s condition which may jeopardize the study.

发起方